Lumosity's diverse, talented team creates digital tools that help users in many areas, such as cognitive training, sleep, and mindfulness. Through the Human Cognition Project, we collaborate with over 100 leading researchers, clinicians and teachers from institutions around the world.
Steve is the CEO of Lumos Labs. He has over 30 years of senior management experience; prior to Lumos Labs, he served as the CEO of Move Inc. (2009 - 2014), running both a SAAS business for real estate professionals and the consumer brand realtor.com. In September 2014, he presided over the $950 million acquisition of Move by News Corp. Earlier in his career, Steve served as the CEO of Ask Jeeves (Ask.com). Steve was credited with building the management team that orchestrated the turnaround of Ask.com. During his tenure there, the company’s value grew from $40 million to $1.85 billion, and in 2005, he led the sale of the business to IAC/InterActive Corporation for $1.85 billion. Steve has also served as the Senior Vice President of the Online Services Group for Microsoft, which included MSN.com, advertising sales, business development, and marketing for Live Platform, Search, MSN and Windows Live. From 1994 to 1999, Steve served as the President and Chief Operating Officer of IDG Books, a company that went public in 1998, where he successfully expanded the "Dummies" series of books into a celebrated consumer brand covering everything from C++ to pet care. Steve began his career in the education and publishing space, and has held senior leadership positions at Intermap Systems, Henry Holt Publishing and MacMillan Publishing. Steve graduated from State University of New York at Albany with a B.A. in Accounting.
Kunal is a co-founder and chairman of the board of Lumos Labs, where he previously served as CEO until 2015. During his tenure at Lumos Labs, Kunal led Lumosity’s growth to 70 million users worldwide, earning the company spots on San Francisco Business Times’ Best Places to Work for four years in a row, Forbes’ America’s Most Promising Companies list, the Inc. 500 list, the Inc. Hire Power Awards, and the Deloitte Technology Fast 500 list. In 2014, Kunal was named one of Goldman Sachs’ 100 Most Intriguing Entrepreneurs. Prior to founding Lumos Labs, Kunal co-founded the private equity fund AIMLP, which manages over $400MM in capital. Prior to founding AIMLP, Kunal was Vice President at McCown De Leeuw and Co., a $1.2 billion private equity fund making growth equity investments. Kunal started his career in the Strategic Planning and Development group at the Walt Disney Company. Kunal graduated magna cum laude from Princeton University with a B.A. in Economics.
Michael Scanlon co-founded Lumos Labs in 2005, where he previously served as the Chief Scientific Officer. At Lumos Labs, he established new research techniques to enable rapid testing of these methods at large-scale. Prior to founding Lumosity, Michael was a neuroscience PhD student at Stanford University where his research included investigation of the neural correlates of human cognitive processes such as memory and attention, neurogenesis in rodents due to exercise and learning, and cellular plasticity initiated by changes in the environment. Michael graduated from Princeton University with an A.B. in Psychology.
Krishna is the CFO of Lumos Labs. Previously, Krishna co-launched the Emerging Technology Research group at Goldman Sachs with a mandate to provide thematic research about disruptive technology trends and related pioneering start-ups. Prior to joining Goldman Sachs, Krishna gained valuable product management and start-up operations experience at NewRiver, a start-up later sold to Broadridge. Krishna began his career at Lazard, working initially in the Life Sciences M&A Group and later at Lazard Technology Partners, an early stage venture capital fund affiliated with Lazard. Krishna received an MBA from Harvard Business School and a B.A. in Philosophy with a Certificate in Applied Mathematics from Princeton University.
Tyler Chapman is VP of Finance, Corporate Controller at Lumos Labs. He oversees the company’s finance and accounting function. He joined the company in 2014 and brings more than 10 years of corporate and public accounting & finance experience to Lumosity. Prior to this role, Tyler spent over three years working in the gaming industry with publicly traded social gaming company Zynga and private gaming company KIXEYE. During this time he performed various accounting and tax management roles. Tyler started his career at PwC and worked in its corporate tax group for seven years. Tyler is a CPA and holds an M.S. in Taxation from Golden Gate University and both an M.S. in Accounting and a B.S. in Accounting from the University of Montana.
Dr. Glenn Morrison is the Director of Clinical Trials of Lumos Labs, where he leads the clinical research efforts. Working with collaborators in pharma, academia, and industry, he is focused on clinical studies to support the effectiveness of Lumosity core training and Lumosity assessments. Dr. Morrison has over 14 years of clinical development experience in biotech/pharma, and most recently at Genentech and Roche was responsible for leading the development of Alzheimer’s Disease compounds into Phase 3. Dr. Morrison earned his M.Sc. and Ph.D in Behavioral Neurobiology from the University of Toronto and did post-doctoral work at UCLA.